ELOX

Eloxx Pharmaceuticals, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1035354) · 2 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

Reverse splits are how companies cure bid-price deficiencies; under 2026 rules they get one per 12 months.

Radar 37 (low attention) · dilution pressure low · listing risk elevated · governance risk low · runway 34.1 mo · strongest signal: Near $5M MVLS floor (Jun 30, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

37Radar · attention score (0–100)

0Dilution pressure · financing + balance sheet

50Listing risk · exchange standards

0Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on ELOX

Alerts

One email the morning ELOX files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for ELOX back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 985 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$62.0Mcash + short-term investments as of Jun 30, 2026

34.1 moestimated runway (4x latest quarterly operating cash burn)

$46.4Mstockholders' equity as of Jun 30, 2026

$330Kpublic float (10-K cover)

4.0Mshares outstanding as of Aug 7, 2026 · was 5.1M Mar 12, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Aug 11, 2026	▼ Reverse split	“reverse split” language in 8-K (EX-99.1) filed 2026-08-11 filing	32
Jun 30, 2026	▼ Near $5M MVLS floor	Public float $330,000 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing	32

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans